Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bioforce Nanosciences Holdings, Inc. (BFNH)
:BFNH
Holding BFNH?
Track your performance easily
BFNH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.16 - $2.08
Previous CloseN/A
Volume3.00K
Average Volume (3M)1.16K
Market Cap
$17.42M
Enterprise ValueN/A
Total Cash (Recent Filing)$14.32K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.22
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding29,271,755
10 Day Avg. Volume846
30 Day Avg. Volume1,156
Standard Deviation0.58
R-Squared0.02
Alpha0.13
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-331.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BFNH FAQ
What was Bioforce Nanosciences Holdings, Inc.’s price range in the past 12 months?
Bioforce Nanosciences Holdings, Inc. lowest stock price was $0.16 and its highest was $2.08 in the past 12 months.
What is Bioforce Nanosciences Holdings, Inc.’s market cap?
Bioforce Nanosciences Holdings, Inc.’s market cap is $17.42M.
When is Bioforce Nanosciences Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bioforce Nanosciences Holdings, Inc.’s earnings last quarter?
Bioforce Nanosciences Holdings, Inc. released its earnings results on May 11, 2018. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
Is Bioforce Nanosciences Holdings, Inc. overvalued?
According to Wall Street analysts Bioforce Nanosciences Holdings, Inc.’s price is currently Overvalued.
Does Bioforce Nanosciences Holdings, Inc. pay dividends?
Bioforce Nanosciences Holdings, Inc. does not currently pay dividends.
What is Bioforce Nanosciences Holdings, Inc.’s EPS estimate?
Bioforce Nanosciences Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioforce Nanosciences Holdings, Inc. have?
Bioforce Nanosciences Holdings, Inc. has 29,271,755 shares outstanding.
What happened to Bioforce Nanosciences Holdings, Inc.’s price movement after its last earnings report?
Bioforce Nanosciences Holdings, Inc. reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Bioforce Nanosciences Holdings, Inc.?
Currently, no hedge funds are holding shares in BFNH
---
Company Description
Bioforce Nanosciences Holdings, Inc.
BioForce Nanosciences Holdings, Inc. provides natural vitamins, minerals, nutritional supplements, powders and beverages. It markets products through social media and telemarketing. The company was founded on December 10, 1999 and is headquartered in Virginia Beach, VA.
---
Technical Analysis
BioRestorative Therapies
―
Creative Medical Technology Holdings
―
Enzolytics
―
Helius Medical Technologies
―
Predictive Technology Group
―
Verastem
―
---